Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2

Abstract

Isocitrate dehydrogenase ( IDH ) genes 1 and 2 are frequently mutated in acute myeloid leukaemia (AML), low-grade glioma, cholangiocarcinoma (CC) and chondrosarcoma (CS). For AML, low-grade glioma and CC, mutant IDH status is associated with a DNA hypermethylation phenotype, implicating altered epigenome dynamics in the aetiology of these cancers. Here we show that the IDH variants in CS are also associated with a hypermethylation phenotype and display increased production of the oncometabolite 2-hydroxyglutarate, supporting the role of mutant IDH-produced 2-hydroxyglutarate as an inhibitor of TET-mediated DNA demethylation. Meta-analysis of the acute myeloid leukaemia, low-grade glioma, cholangiocarcinoma and CS methylation data identifies cancer-specific effectors within the retinoic acid receptor activation pathway among the hypermethylated targets. By analysing sequence motifs surrounding hypermethylated sites across the four cancer types, and using chromatin immunoprecipitation and western blotting, we identify the transcription factor EBF1 (early B-cell factor 1) as an interaction partner for TET2, suggesting a sequence-specific mechanism for regulating DNA methylation.

References 38

1. 1.

   Tang C.-H. Molecular mechanisms of chondrosarcoma metastasis. Biomedicine. 2, 92–98 (2012 ).

   Not in our library

2. 2.

   Amary M. F.. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J. Pathol. 224, 334–343 (2011 ).

   Not in our library10.1002/path.2913

3. 3.

   Amary M. F.. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat. Genet. 43, 1262–1265 (2011 ).

   Not in our library10.1038/ng.994

4. 4.

   Dang L., Jin S. & Su S. M. IDH mutations in glioma and acute myeloid leukemia. Trends Mol. Med. 16, 387–397 (2010 ).

   Not in our library10.1016/j.molmed.2010.07.002

5. 5.

   Wang P.. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 32, 3091–3100 (2012 ).

   Not in our library10.1038/onc.2012.315

6. 6.

   Xu W.. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17–30 (2011 ).

   Not in our library10.1016/j.ccr.2010.12.014

7. 7.

   Turcan S.. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479–483 (2012 ).

   Not in our library10.1038/nature10866

8. 8.

   Figueroa M. E.. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18, 553–567 (2010 ).

   Not in our library10.1016/j.ccr.2010.11.015

9. 9.

   Tahiliani M.. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930–935 (2009 ).

   Not in our library10.1126/science.1170116

10. 10.

    He Y. F.. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303–1307 (2011 ).

    Not in our library10.1126/science.1210944

11. 11.

    Ito S.. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300–1303 (2011 ).

    Not in our library10.1126/science.1210597

12. 12.

    Bibikova M.. High density DNA methylation array with single CpG site resolution. Genomics 98, 288–295 (2011 ).

    Not in our library10.1016/j.ygeno.2011.07.007

13. 13.

    Rakyan V. K., Down T. A., Balding D. J. & Beck S. Epigenome-wide association studies for common human diseases. Nat. Rev. Genet. 12, 529–541 (2011 ).

    Not in our library10.1038/nrg3000

14. 14.

    Portela A. & Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol. 28, 1057–1068 (2010 ).

    Not in our library10.1038/nbt.1685

15. 15.

    Ye D., Xiong Y. & Guan K. L. The mechanisms of IDH mutations in tumorigenesis. Cell. Res. 22, 1102–1104 (2012 ).

    Not in our library10.1038/cr.2012.51

16. 16.

    Khulan B.. Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res. 16, 1046–1055 (2006 ).

    Not in our library10.1101/gr.5273806

17. 17.

    Bailey T. L.. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202–W208 (2009 ).

    Not in our library10.1093/nar/gkp335

18. 18.

    Eckhardt F.. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 38, 1378–1385 (2006 ).

    Not in our library10.1038/ng1909

19. 19.
    The DNA Methylome of Human Peripheral Blood Mononuclear Cells · 2010

    No notice
20. 20.

    Ryan R. J. & Bernstein B. E. Molecular biology. Genetic events that shape the cancer epigenome. Science 336, 1513–1514 (2012 ).

    Not in our library10.1126/science.1223730

21. 21.

    Tarpey P. S.. Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat. Genet (e-pub ahead of print 16 June 2013; doi:10.1038/ng.2668).

    Not in our library10.1038/ng.2668

22. 22.

    Weissmann S.. Landscape of TET2 mutations in acute myeloid leukemia. Leukemia 26, 934–942 (2012 ).

    Not in our library10.1038/leu.2011.326

23. 23.

    Kim Y. H.. TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations. J. Clin. Pathol. 64, 850–852 (2011 ).

    Not in our library10.1136/jclinpath-2011-200133

24. 24.

    Tang X. H. & Gudas L. J. Retinoids, retinoic acid receptors, and cancer. Annu. Rev. Pathol. 6, 345–364 (2011 ).

    Not in our library10.1146/annurev-pathol-011110-130303

25. 25.

    Soprano K. J. & Soprano D. R. Retinoic acid receptors and cancer. J. Nutr. 132, 3809S–3813S (2002 ).

    Not in our library10.1093/jn/132.12.3809s

26. 26.

    Duncan C. G.. A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation. Genome Res. 22, 2339–2355 (2012 ).

    Not in our library10.1101/gr.132738.111

27. 27.

    Kim K.. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285–290 (2010 ).

    Not in our library10.1038/nature09342

28. 28.

    Maier H.. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription. Nat. Immunol. 5, 1069–1077 (2004 ).

    Not in our library10.1038/ni1119

29. 29.

    Treiber T.. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin. Immunity 32, 714–725 (2010 ).

    Not in our library10.1016/j.immuni.2010.04.013

30. 30.

    Thirlwell C.. Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. Methods 52, 248–254 (2010 ).

    Not in our library10.1016/j.ymeth.2010.04.012

31. 31.

    Bolstad B. M. preprocessCore: a collection of pre-processing functions. R package version 1.18.0.

    Not in our library

32. 32.

    Yang Y. H. marray: exploratory analysis for two-color spotted microarray data. R package version 1.34.0 (2009 ).

    Not in our library

33. 33.

    Day A. heatmap.plus: heatmap with more sensible behavior. R package version 1.3 (2007 ).

    Not in our library

34. 34.

    Warnes G. R. gtools: various R programming tools. R package version 2.7.0 ( http://CRAN.R-project.org/package=gtools) (2012 ).

    Not in our library

35. 35.
    An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer · 2009

    No notice
36. 36.

    Benjamini Y. & Hochberg Y. Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J. Roy. Stat. Soc. B Met. 57, 289–300 (1995 ).

    Not in our library

37. 37.

    Krueger F., Kreck B., Franke A. & Andrews S. R. DNA methylome analysis using short bisulfite sequencing data. Nat. Methods. 9, 145–151 (2012 ).

    Not in our library10.1038/nmeth.1828

38. 38.

    Krueger F. & Andrews S. R. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 27, 1571–1572 (2011 ).

    Not in our library10.1093/bioinformatics/btr167

Cited by papers we hold 10

• TET (Ten-eleven translocation) family proteins: structure, biological functions and applications · 2023
  No notice
• A genome-scale map of DNA methylation turnover identifies site-specific dependencies of DNMT and TET activity · 2020
  No notice
• TET Enzymes and 5hmC in Adaptive and Innate Immune Systems · 2019
  No notice
• EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells. · 2017
  Not checked
• Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis · 2016
  No notice
• Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility · 2016
  No notice
• TET proteins and the control of cytosine demethylation in cancer · 2015
  No notice
• Pan-cancer patterns of DNA methylation · 2014
  No notice
• Using high-density DNA methylation arrays to profile copy number alterations · 2014
  No notice
• Age-associated epigenetic drift: implications, and a case of epigenetic thrift? · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.